Bharat Parenterals Ltd
Ticker: BPLPHARMA
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
1209.50
Market Cap
833.58
Debt/Equity
0.5316
ROE %
-4.373
PB
2.4589
Promoter %
67.194
Pledge %
0.000
1Y Rev Growth %
32.381
5Y Rev Growth %
7.991
NP Margin %
-3.585
NP Margin 5Y Avg %
5.632
Trading Reference
1M Return %
-1.339
6M Return %
22.431
1Y Return %
-17.682
% Away 52W High
54.609
% Away 52W Low
50.810
Daily Volume
283
Investment Verdict
Hold
Score 62/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 33/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Bharat Parenterals Ltd shows potential for growth in the pharmaceutical sector, driven by increasing demand for injectables.
✅ Positives
- Strong product portfolio in injectables
- Growing market demand for pharmaceuticals
- Robust financial performance in recent quarters
⚠️ Negatives
- High competition in the pharmaceutical industry
- Regulatory challenges affecting production
- Dependence on a few key clients
Verdict
Moderate growth potential with some risks.
Recommendation: Consider buying on dips.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 30/10/2025
More Options
T
Tembo Global Industries Ltd
Tembo Global Industries Ltd shows some potential but faces challenges in growth consistency and market sentiment.
View details
A
A B Cotspin India Ltd
A B Cotspin India Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in growth and profitability metrics, making it a risky investment at this time.
View details
M
Mac Charles (India) Ltd
Mac Charles (India) Ltd shows potential in a recovering sector, but faces challenges in growth consistency and profitability.
View details
S
Silver Touch Technologies Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
M
Munjal Auto Industries Ltd
Munjal Auto Industries Ltd shows potential but faces challenges in growth consistency and market positioning.
View details
T
Tuticorin Alkali Chemicals and Fertilizers Ltd
The stock shows potential but is hindered by inconsistent growth and governance issues.
View details
K
Kody Technolab Ltd
Kody Technolab Ltd shows potential but faces challenges in growth consistency and valuation metrics. Caution is advised.
View details
L
Le Merite Exports Ltd
Le Merite Exports Ltd shows potential in a growing sector, but inconsistencies in growth and profitability metrics warrant caution.
View details
R
RDB Infrastructure and Power Ltd
RDB Infrastructure and Power Ltd faces significant challenges in growth and profitability, with a risky outlook due to market sentiment and execution risks.
View details
K
Kothari Petrochemicals Ltd
Kothari Petrochemicals Ltd shows potential but faces several challenges that could impact future performance.
View details
S
Sandesh Ltd
Sandesh Ltd faces significant challenges in adapting to a rapidly changing media landscape, with inconsistent growth and profitability metrics. Caution is advised for potential investors.
View details
A
ADC India Communications Ltd
ADC India Communications Ltd shows potential in a growing sector, but faces challenges in growth consistency and profitability metrics.
View details
B
Best Agrolife Ltd
Best Agrolife Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
R
R & B Denims Ltd
R & B Denims Ltd presents a risky investment opportunity with several concerns regarding growth consistency and market sentiment.
View details
M
Mercury Ev-Tech Ltd
Mercury Ev-Tech Ltd operates in a promising sector but faces challenges in growth consistency and profitability metrics.
View details
A
Allcargo Gati Ltd
Allcargo Gati Ltd faces significant challenges in growth and profitability, making it a risky investment.
View details
Business Overview
Bharat Parenterals Ltd is a leading Indian manufacturer specializing in sterile injectable pharmaceuticals. Catering to hospitals, clinics, and healthcare providers, the company plays a crucial role in ensuring the availability of essential medications. With a commitment to quality and compliance with international standards, Bharat Parenterals is well-positioned to meet the growing demand for high-quality injectables in India and abroad. Their focus on innovation and sustainability further enhances their reputation in the pharmaceutical industry.
- Leading manufacturer of sterile injectables
- Serves hospitals and healthcare providers
- Commitment to quality and international standards
- Innovative solutions for the pharmaceutical market
- Sustainable practices in production
- Strong growth potential in the healthcare sector
Investment Thesis
Bharat Parenterals Ltd stands out due to its credible promoter group, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company for sustainable growth and value creation, making it a compelling investment opportunity for retail investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with industry trends.
- Attractive valuation compared to peers presents a favorable entry point.
- Focus on quality manufacturing supports long-term business sustainability.
- Strategic initiatives may lead to increased market share and profitability.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceuticals
- Expansion into international markets
- Strong product pipeline
- Government support for healthcare sector
Risks ⚠️
- Regulatory challenges
- Intense competition in industry
- Dependence on key customers
- Fluctuating raw material costs
Peer Perspective
Bharat Parenterals Ltd trades at a discount to peers like Sun Pharmaceutical and Cipla, primarily due to margin volatility. A stable margin improvement could trigger a rerating, aligning its valuation with industry standards.
Future Outlook
Bharat Parenterals Ltd is well-positioned for growth, driven by its expanding product portfolio and market demand; however, successful execution and stringent cost control will be crucial to achieving its long-term objectives.
📊 Stock Investment Checklist (100 Points)
Bharat Parenterals Ltd • Updated: 2025-09-17 01:35:21
-
10BusinessHighPharmaceutical sector shows growth potential, but competition is intense.
-
10GrowthHighConsistent revenue growth observed, but profit margins are fluctuating.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is not consistently higher than net profit.
-
8ValuationHighP/E and P/B ratios are slightly above industry average.
-
7BalanceHighModerate debt levels, but liquidity ratios are satisfactory.
-
6GovernanceGoodPromoter holding is stable, but some pledging observed.
-
5DriversGoodGrowth drivers exist, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Bharat Parenterals Ltd shows potential for growth, but faces challenges in profitability and market competition.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 60/100